Dr. Weston Wall, MD

Dr. Wall practices at Florida Dermatology & Skin Cancer Centers in Winter Haven, Florida.

Dr. Wall's NPI, 1437512969, was assigned on April 1, 2016. Dr. Wall graduated from University Of Louisville School Of Medicine in 2016. Dr. Wall holds Florida license ME148685.

Dr. Wall's primary practice is Florida Dermatology & Skin Cancer Centers, at 1450 6th SE St, Winter Haven, FL 33880 in Polk County. The practice phone is (863) 293-2147.

Dr. Wall's primary practice is Florida Dermatology & Skin Cancer Centers in Winter Haven, Florida. The medical group on file is Premier Dermatology LLC. Dmand AI also links Dr. Wall to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wall practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Wall's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Wall is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Wall's licenses on file in 3 states: Florida, South Carolina and Georgia.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, psoriasis and scalp rash among the conditions Dr. Wall treats.

CMS data shows 1,739 Medicare services from Dr. Wall across 25 procedure codes in 2024, for 404 Medicare patients. Medicare paid $265,042 for them. Every service was in an office.

CMS counts 404 Medicare patients who saw Dr. Wall in 2024. The largest group is 75 to 84, with 179 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wall's median patient age at 71, with 46% women.

In 2024, Dr. Wall wrote 1,173 Medicare Part D claims for 731 patients. 100% of them were for generic drugs. CMS names the drug for 1,107 of them, across 10 drugs with 11 or more claims each, at $6,737 in total drug cost. In 2023, CMS named 2,055 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Wall for performance year 2024, reported individually. Dr. Wall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 143 procedures of melanoma (skin cancer) excision by Dr. Wall, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Wall, published from 2018 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Carcinoma, Merkel Cell and Skin Neoplasms. Dr. Wall has published most often in JAAD Case Rep. Dr. Wall's most frequent co-authors are Jeffrey M. Bumpous, MD, Neal Dunlap, MD and Paul Albert Tennant, MD.

CMS Open Payments shows 61 general payments to Dr. Wall from 15 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $298.

Dr. Wall graduated from University Of Louisville School Of Medicine in 2016.

Dr. Wall is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.